| 000 | 01471 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517190311.0 | ||
| 264 | 0 | _c20180124 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1872-9142 | ||
| 024 | 7 |
_a10.1016/j.molimm.2017.11.027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeizer, M P | |
| 245 | 0 | 0 |
_aAsparaginase inhibits the lectin pathway of complement activation. _h[electronic resource] |
| 260 |
_bMolecular immunology _c01 2018 |
||
| 300 |
_a189-192 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aComplement Pathway, Mannose-Binding Lectin _xdrug effects |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMannose-Binding Lectin _xblood |
| 650 | 0 | 4 |
_aMannose-Binding Protein-Associated Serine Proteases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 700 | 1 | _aAarts, C | |
| 700 | 1 | _aKamp, A M | |
| 700 | 1 | _aCaron, H N | |
| 700 | 1 | _avan de Wetering, M D | |
| 700 | 1 | _aWouters, D | |
| 700 | 1 | _aKuijpers, T W | |
| 773 | 0 |
_tMolecular immunology _gvol. 93 _gp. 189-192 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molimm.2017.11.027 _zAvailable from publisher's website |
| 999 |
_c27846996 _d27846996 |
||